Literature DB >> 1304577

Immunomodulation of low dose streptozocin diabetes in mice reveals that insulitis is not obligatory for B cell destruction.

G Papaccio1, G Chieffi Baccari, V Esposito.   

Abstract

Twenty male C57Bl/J mice were injected with 50 microliters complete Freund's adjuvant (CFA) 1 wk before and 1 wk after induction of diabetes with 45 mg streptozocin (STZ)/kg body weight i.p. over 5 d. CFA administration prevented islet infiltration. Inflammatory cells were not seen within any of the islets observed. However, islet B cell destruction still occurred. These cells showed evidence of considerable damage, containing swollen mitochondria, contracted nuclei and areas of vacuolation and degranulation. Inflammation is therefore not obligatory for the development of low dose STZ induced diabetes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1304577      PMCID: PMC1259692     

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  13 in total

1.  Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy.

Authors:  T Wang; B Singh; G L Warnock; R V Rajotte
Journal:  Diabetes       Date:  1992-01       Impact factor: 9.461

2.  The role of natural suppressor and natural killer activities in resistance to hemopoietic transplantation in unirradiated hosts.

Authors:  M W Sadelain; M Voralia; D R Green; T G Wegmann
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

3.  Synergistic effects of adjuvants, endotoxin, and fasting on induction of diabetes with multiple low doses of streptozocin in rats.

Authors:  J R Wright; P E Lacy
Journal:  Diabetes       Date:  1988-01       Impact factor: 9.461

Review 4.  Drugs producing diabetes through damage of the insulin secreting cells.

Authors:  C C Rerup
Journal:  Pharmacol Rev       Date:  1970-12       Impact factor: 25.468

5.  Multiple low dose streptozocin-treated rats: biochemical and morphological effects of cyclosporin A administration.

Authors:  G Papaccio; V Esposito; V Mezzogiorno
Journal:  Cell Mol Biol       Date:  1989       Impact factor: 1.770

6.  Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.

Authors:  M W Sadelain; H Y Qin; J Lauzon; B Singh
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

7.  Further morphological and biochemical observations on early low dose streptozocin diabetes in mice.

Authors:  G Papaccio; T Linn; K Federlin; A Volkman; V Esposito; V Mezzogiorno
Journal:  Pancreas       Date:  1991-11       Impact factor: 3.327

8.  Ultrastructural observations on cytotoxic effector cells infiltrating pancreatic islets of low-dose streptozocin treated mice.

Authors:  G Papaccio; V Esposito
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

9.  Effect of cyclosporine and aminophylline on streptozotocin-induced diabetes in rats.

Authors:  E Ferrero; A Marni; M E Ferrero; G Gaja; C Rugarli
Journal:  Immunol Lett       Date:  1985       Impact factor: 3.685

10.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

Authors:  G F Bottazzo; B M Dean; J M McNally; E H MacKay; P G Swift; D R Gamble
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

View more
  1 in total

1.  The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin.

Authors:  G Papaccio; M Latronico; G Chieffi Baccari
Journal:  Cell Tissue Res       Date:  1994-09       Impact factor: 5.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.